Al Hammadi Company for Development and Investment to acquire a 35% stake in Sudair Pharmaceuticals from Gulf Investment for $32m.

Synopsis

Al Hammadi Company for Development and Investment, a hospitals and medical centers operator, agreed to acquire a 35% stake in Sudair Pharmaceuticals, a pharmaceutical company, from Gulf Investment, an investment company, for $32m.

Principals

target

Sudair Pharmaceuticals

bidder

Al Hammadi Company For Development And Investment

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

yasser alobaida

Founder and CEO at SUDAIR PHARMACEUTICALS

Manager

target

Deal

£ 24 M

Total Value

Bidder Team (1)

mohammad bin saleh mohammad al-hammadi

Executive Director and CEO at AL HAMMADI COMPANY FOR DEVELOPMENT AND INVESTMENT

Manager

bidder

Deal

£ 24 M

Total Value

Vendor Team (2)

simon rahimzada

Partner at King & Spalding

Lawyer

vendor

Deals

£ 1.07 B

Total Value

jassim seddiqi

CEO at GULF INVESTMENT CORPORATION

Investor

vendor

Deal

£ 24 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy